As of 2025-09-13, the Relative Valuation of Abbott Laboratories (ABT) is 212.86 USD. This relative valuation is based on P/E multiples. With the latest stock price at 133.73 USD, the upside of Abbott Laboratories based on Relative Valuation is 59.2%.
The range of the Relative Valuation is 128.52 - 353.56 USD.
| Range | Selected | |
| Trailing P/E multiples | 30.3x - 44.0x | 36.6x |
| Forward P/E multiples | 31.0x - 35.3x | 31.8x |
| Fair Price | 128.52 - 353.56 | 212.86 |
| Upside | -3.9% - 164.4% | 59.2% |
| Date | P/E |
| 2025-09-12 | 16.65 |
| 2025-09-11 | 16.52 |
| 2025-09-10 | 16.11 |
| 2025-09-09 | 16.43 |
| 2025-09-08 | 16.46 |
| 2025-09-05 | 16.55 |
| 2025-09-04 | 16.54 |
| 2025-09-03 | 16.46 |
| 2025-09-02 | 16.37 |
| 2025-08-29 | 16.52 |
| 2025-08-28 | 16.36 |
| 2025-08-27 | 16.37 |
| 2025-08-26 | 16.38 |
| 2025-08-25 | 16.42 |
| 2025-08-22 | 16.51 |
| 2025-08-21 | 16.43 |
| 2025-08-20 | 16.49 |
| 2025-08-19 | 16.34 |
| 2025-08-18 | 16.22 |
| 2025-08-15 | 16.40 |
| 2025-08-14 | 16.10 |
| 2025-08-13 | 16.11 |
| 2025-08-12 | 16.31 |
| 2025-08-11 | 16.36 |
| 2025-08-08 | 16.72 |
| 2025-08-07 | 16.44 |
| 2025-08-06 | 16.30 |
| 2025-08-05 | 16.27 |
| 2025-08-04 | 16.18 |
| 2025-08-01 | 15.85 |
| 2025-07-31 | 15.71 |
| 2025-07-30 | 16.01 |
| 2025-07-29 | 15.94 |
| 2025-07-28 | 15.73 |
| 2025-07-25 | 15.75 |
| 2025-07-24 | 15.64 |
| 2025-07-23 | 15.67 |
| 2025-07-22 | 15.65 |
| 2025-07-21 | 15.49 |
| 2025-07-18 | 15.40 |
| 2025-07-17 | 15.00 |
| 2025-07-16 | 16.40 |
| 2025-07-15 | 16.37 |
| 2025-07-14 | 16.44 |
| 2025-07-11 | 16.44 |
| 2025-07-10 | 16.63 |
| 2025-07-09 | 16.59 |
| 2025-07-08 | 16.60 |
| 2025-07-07 | 16.65 |
| 2025-07-03 | 16.74 |